Friday, November 27, 2020

AstraZeneca plans new vaccine trial as efficacy questioned

The announcement comes days after the vaccine developers said their two-shot inoculation was 70% effective in preventing Covid-19 in an interim analysis of their clinical trial, with a particular regimen in which the first shot was at half-strength showing a higher 90% efficacy.

Posted from: this blog via Microsoft Flow.

No comments:

Post a Comment